| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $2.36 ▲ +1.77% | Yesterday | $2.30 ▼ -0.74% | Tomorrow's Neumora Therapeutics Inc. Common Stock (NMRA) setup is anchored to $2.32 and targets $2.36 (+1.77%). The near-term read is upside; watch $2.39 / $2.25 because daily realized volatility is about 8.00%. |
Tomorrow's Neumora Therapeutics Inc. Common Stock (NMRA) setup is anchored to $2.32 and targets $2.36 (+1.77%). The near-term read is upside; watch $2.39 / $2.25 because daily realized volatility is about 8.00%. | ||||
| Week | $2.45 ▲ +5.50% | Last Week | $2.27 ▼ -2.31% | The 7-day Neumora Therapeutics Inc. Common Stock model moves from $2.27 to $2.45 (+5.50%). It gives upside momentum context for this stock, so breaks around $2.39 / $2.25 matter more than a single tick. |
The 7-day Neumora Therapeutics Inc. Common Stock model moves from $2.27 to $2.45 (+5.50%). It gives upside momentum context for this stock, so breaks around $2.39 / $2.25 matter more than a single tick. | ||||
| Month | $2.59 ▲ +11.71% | Last Month | $2.21 ▼ -4.92% | The 1-month Neumora Therapeutics Inc. Common Stock target is $2.59 (+11.71%), compared with the live reference near $2.32. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Neumora Therapeutics Inc. Common Stock target is $2.59 (+11.71%), compared with the live reference near $2.32. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $2.81 ▲ +21.03% | Last Year | $2.12 ▼ -8.83% | The 1-year Neumora Therapeutics Inc. Common Stock scenario points to $2.81 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Neumora Therapeutics Inc. Common Stock scenario points to $2.81 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $3.31 ▲ +42.86% | 5 Years Ago | $1.90 ▼ -18.00% | The 5-year Neumora Therapeutics Inc. Common Stock view is $3.31 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Neumora Therapeutics Inc. Common Stock view is $3.31 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $2.32 | Mid |
| Daily Change | +5.94% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 70% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $2.32 | Daily Change | +5.94% |
| Market Cap | $423.84M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.